AnastrozoleA Review of its Use in the Management of Postmenopausal Women with Advanced Breast Cancer

被引：0
作者：
Lynda R. Wiseman
Julie C. Adkins
机构：
[1] Adis International Limited,
来源：
Drugs & Aging | 1998年 / 13卷
关键词：
Aromatase Inhibitor; Advanced Breast Cancer; Letrozole; Anastrozole; Megestrol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Anastrozole is a new oral nonsteroidal aromatase inhibitor indicated for the second-line endocrine treatment of postmenopausal women with advanced breast cancer. In postmenopausal women, anastrozole significantly reduces plasma estrogen levels; maximal suppression is achieved at dosages ≥1 mg/day and levels remain suppressed during long term therapy.
引用
收藏
页码：321 / 332
页数：11
相关论文
共 74 条
[31]  
Lonning PE(undefined)undefined undefined undefined undefined-undefined
[32]  
Yates RA(undefined)undefined undefined undefined undefined-undefined
[33]  
Dowsett M(undefined)undefined undefined undefined undefined-undefined
[34]  
Fisher GV(undefined)undefined undefined undefined undefined-undefined
[35]  
Lønning PE(undefined)undefined undefined undefined undefined-undefined
[36]  
Geisler J(undefined)undefined undefined undefined undefined-undefined
[37]  
King N(undefined)undefined undefined undefined undefined-undefined
[38]  
Kleeberg UR(undefined)undefined undefined undefined undefined-undefined
[39]  
Dowsett M(undefined)undefined undefined undefined undefined-undefined
[40]  
Carrion RP(undefined)undefined undefined undefined undefined-undefined
12345678